SeaStar Medical Holding Corp
ICUNasdaq
$4.00
↓ -5.2%Jul 17 close · end-of-day
Price
1Y↓ -34.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$15.7M
Enterprise Value
$15.7M
P/E
—
P/S
10.9
P/B
2.1
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$1.4M
Net Income (TTM)
-$11.9M
Free Cash Flow (TTM)
—
Gross Margin
93.1%
Operating Margin
-832.6%
Net Margin
—
ROE
—
ROIC
-129.1%
Debt / Equity
—
Net Cash
—
Return 1Y
-39.8%
Company profile
LMF Acquisition Opportunities, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was incorporated in 2020 and is based in Tampa, Florida.
- CEO
- Eric Schlorff
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 2
- Headquarters
- Colorado
- Website
- N/A
Management & directors
- Chung KevinChief Medical Officer
- Schlorff EricChief Executive Officer
- Towne Bradford KPrincipal Accounting Officer
- Messinger MichaelChief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
ICU Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$495,000.00↑ +68.9%
Diluted EPS——
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $135,000.00 | $1.2M |
| Gross profit | — | — | $0.00 | $135,000.00 | $1.2M |
| Operating income | -$4.4M | -$11.6M | -$14.2M | -$17.8M | -$12.2M |
| Net income | -$4.6M | -$12.2M | -$26.2M | -$24.8M | -$12.2M |
| Diluted EPS | -$0.63 | -$1.48 | -$30.26 | -$6.63 | — |
| Operating cash flow | -$5.1M | -$7.8M | -$10.3M | -$16.0M | -$13.6M |
| Free cash flow | — | — | — | — | — |
| Gross margin | — | — | — | 100.0% | 95.7% |
| Operating margin | — | — | — | -13216.3% | -986.6% |
| Net margin | — | — | — | -18392.6% | -984.6% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $68,000.00 | $67,000.00 | $293,000.00 | $338,000.00 | $183,000.00 | $420,000.00 | $495,000.00 |
| Gross profit | $0.00 | $68,000.00 | $67,000.00 | $293,000.00 | $311,000.00 | $169,000.00 | $408,000.00 | $449,000.00 |
| Operating income | -$4.7M | -$4.5M | -$4.8M | -$3.8M | -$1.8M | -$3.6M | -$3.0M | -$3.6M |
| Net income | -$3.2M | -$4.5M | -$4.4M | -$3.8M | -$2.0M | -$3.5M | -$2.9M | -$3.5M |
| Diluted EPS | -$1.03 | -$1.10 | $0.23 | -$0.44 | -$0.18 | — | — | — |
| Operating cash flow | -$2.8M | -$5.0M | -$4.7M | -$2.7M | -$3.0M | -$3.8M | -$4.1M | -$2.8M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | 100.0% | 100.0% | 100.0% | 92.0% | 92.3% | 97.1% | 90.7% |
| Operating margin | — | -6552.9% | -7114.9% | -1304.4% | -519.5% | -1955.7% | -718.6% | -727.9% |
| Net margin | — | -6585.3% | -6595.5% | -1287.4% | -592.3% | -1897.3% | -691.4% | -711.3% |
Company news
Jun 30, 2026
Jun 23, 2026
Jun 22, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Schlorff Eric· Chief Executive Officer | Award | 10,288 | $0.00 | $0.00 | filing |
| 2026-07-01 | Chung Kevin· Chief Medical Officer | Award | 7,202 | $0.00 | $0.00 | filing |
| 2026-07-01 | Vincent Bernadette N | Award | 4,000 | $0.00 | $0.00 | filing |
| 2026-07-01 | Neuman John | Award | 4,000 | $0.00 | $0.00 | filing |
| 2026-07-01 | Van Heel Kenneth | Award | 4,000 | $0.00 | $0.00 | filing |
| 2026-07-01 | Baird Jennifer A | Award | 4,000 | $0.00 | $0.00 | filing |
| 2026-02-06 | Van Heel Kenneth | Award | 3,000 | $0.00 | $0.00 | filing |
| 2026-02-06 | Neuman John | Award | 3,000 | $0.00 | $0.00 | filing |
| 2026-02-06 | Vincent Bernadette N | Award | 3,000 | $0.00 | $0.00 | filing |
| 2026-02-06 | Baird Jennifer A | Award | 3,000 | $0.00 | $0.00 | filing |
| 2026-02-06 | Towne Bradford K· Principal Accounting Officer | Award | 7,500 | $0.00 | $0.00 | filing |
| 2026-02-06 | Chung Kevin· Chief Medical Officer | Award | 15,000 | $0.00 | $0.00 | filing |
| 2026-02-06 | Schlorff Eric· Chief Executive Officer | Award | 30,000 | $0.00 | $0.00 | filing |
| 2025-12-19 | Baird Jennifer A | Buy | 4,200 | $0.24 | $987.42 | filing |
| 2025-12-09 | Messinger Michael· Chief Financial Officer | Buy | 14,500 | $0.35 | $5,098.20 | filing |
| 2025-08-27 | Van Heel Kenneth | Buy | 10,000 | $0.86 | $8,565.00 | filing |
| 2025-08-26 | Van Heel Kenneth | Buy | 25,000 | $0.89 | $22,247.50 | filing |
| 2025-08-22 | Chung Kevin· Chief Medical Officer | Buy | 10,000 | $0.80 | $8,000.00 | filing |
| 2025-07-10 | Baird Jennifer A | Award | 4,000 | $0.00 | $0.00 | filing |
| 2025-07-10 | Neuman John | Award | 4,000 | $0.00 | $0.00 | filing |
| 2025-07-10 | Vincent Bernadette N | Award | 4,000 | $0.00 | $0.00 | filing |
| 2025-07-10 | Van Heel Kenneth | Award | 4,000 | $0.00 | $0.00 | filing |
| 2025-07-01 | Chung Kevin· Chief Medical Officer | Option exercise | 5,000 | $0.00 | $0.00 | filing |
| 2025-07-01 | Schlorff Eric· Chief Executive Officer | Option exercise | 21,667 | $0.00 | $0.00 | filing |
| 2025-06-30 | Baird Jennifer A | Buy | 10,000 | $0.42 | $4,174.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.